Actualités
janvier
Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians’ survey—communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis
Veille bibliographique - Janvier 2023
Miljic P, Noureldin A, Lavin M, Kazi S, Sanchez-Luceros A, James PD, et al. J Thromb Haemost 2023 ; 21 : 154-63.
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study
Veille bibliographique - Janvier 2023
Bistervels IM, Wiegers HMG, Ní Áinle F , Bleker SM, Chauleur C, Donnelly J, et al. J Thromb Haemost 2023 ; 21 : 57-67.
Inhibition de l’ADAMTS13 pour traiter le syndrome de Willebrand acquis pendant l’implantation d’un dispositif d’assistance circulatoire mécanique
Analyse Commentée - 11 janvier 2023
Laurie TALON Rev Francoph Hémost Thromb 2023 ; 5 (1) : A1. Deconinck SJ, Nix C, Barth S, Bennek‐Schöpping E, Rauch A, Schelpe A, et al. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation. J Thromb Haemost 2022 ; 20 : 2797-809.
